Drug Profile
Research programme: immunotherapeutics - OnkologixRx
Alternative Names: Onko 1Latest Information Update: 23 Aug 2023
Price :
$50
*
At a glance
- Originator OnkologixRx
- Developer Larrea Biosciences Corporation; OnkologixRx
- Class Cancer vaccines; Influenza virus vaccines
- Mechanism of Action Immunostimulants; Intracellular signalling peptide and protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Gastric cancer; Influenza virus infections
Most Recent Events
- 23 Aug 2023 Discontinued - Preclinical for Gastric cancer in China (Parenteral)
- 23 Aug 2023 Discontinued - Preclinical for Gastric cancer in USA (Parenteral)
- 23 Aug 2023 Discontinued for Influenza virus infections in USA (Parenteral)